Switcher

Theme Color Mode:

Light

Dark

Directions:

LTR

RTL

Navigation Styles:

Vertical

Horizontal

Navigation Menu Style:

Menu Click

Menu Hover

Icon Click

Icon Hover

Note:Works same for both Vertical and Horizontal

Sidemenu Layout Syles:

Default Menu

Closed Menu

Icon Text

Icon Overlay

Detached

Double Menu

Note:Navigation menu styles won't work here.

Page Styles:

Regular

Classic

Modern

Layout Width Styles:

FullWidth

Boxed

Menu Positions:

Fixed

Scrollable

Header Positions:

Fixed

Scrollable

Menu Colors:

Light Menu

Dark Menu

Color Menu

Gradient Menu

Transparent Menu

Note:If you want to change color Menu dynamically change from below Theme Primary color picker.

Header Colors:

Light Header

Dark Header

Color Header

Gradient Header

Transparent Header

Note:If you want to change color Header dynamically change from below Theme Primary color picker.

Theme Primary:

Theme Background:

Menu With Background Image:

MAIN
Home
Dictionary
Infomation
About Us
Contact
Blog

Paper Details

Home
Paper Details

Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.

Author: CanterB, KaradenizC, OğuzA, SerdaroğluA

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study investigated the incidence rate of convulsions associated with imipenem/cilastatin in children with systemic malignancies. 3.6% of patients experienced seizures, suggesting a potential risk in this population.

Paper Details　

Original Abstract of the Article :

Proconvulsive tendency of imipenem/cilastatin is one of its well-known side effects. Most studies report incidence rates ranging from 1.5 to 3%. There is no study on the incidence rate among children with systemic malignancies. Eighty-two patients with various malignancies who received imipenem/cila...See full text at original site

Dr.Camel's Paper Summary Blog

in preparation

Date :

Date Completed 2001-03-15
Date Revised 2019-10-25

Further Info :

Pubmed ID

DOI: Digital Object Identifier

10.1080/08880010050122852

Related Literature

Article Analysis

・Side Effects of imipenem

SNS

PICO Info

in preparation

Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.

The health and medical information provided on Health Journal is not medical advice and should not be considered a substitute for professional medical diagnosis or treatment. Data sources and disclaimers (data limitations, copyright, etc.)Please review our full disclaimer.Information related to health and medicine is based on PubMed data provided by the U.S. National Library of Medicine (NLM).

Copyright © 2024 Health Journal BETA ver. All rights reserved